Ulrike Burk
Impact in
- Cancer Research top 0.5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 2%
- Cancer Cells and Metastasis
- Pancreatic and Hepatic Oncology Research
Papers in
-
- Advanced biosensing and bioanalysis techniques 1
- Signaling Pathways in Disease 1
- Metabolism, Diabetes, and Cancer 1
- Kruppel-like factors research 1
- Oncology 6
- Cancer Cells and Metastasis 3
- Co-authors
- Thomas Brabletz (6 shared papers)Ulrich F. Wellner (4 shared papers)Jörg Schubert (3 shared papers)Otto Schmalhofer (2 shared papers)Simone Spaderna (1 shared paper)Elizabeth Vincan (1 shared paper)Simone Brabletz (4 shared papers)Marc P. Stemmler (2 shared papers)
- Journals
- International Journal of Oncology (2 papers)The EMBO Journal (1 paper)Nature Cell Biology (1 paper)BMC Systems Biology (1 paper)Oncotarget (1 paper)
- Partner nations
- GermanyUnited KingdomUnited States
In The Last Decade
Ulrike Burk
14 papers receiving 3.6k citations
Ulrike Burk's Hit Papers
Peers
Comparison fields: 5 of 96
- Cancer Research 1.9k
- Oncology 1.4k
- Molecular Biology 2.7k
- Cell Biology 220
- Immunology 196
Countries citing papers authored by Ulrike Burk
This map shows the geographic impact of Ulrike Burk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrike Burk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrike Burk more than expected).
Fields of papers citing papers by Ulrike Burk
This network shows the impact of papers produced by Ulrike Burk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrike Burk. The network helps show where Ulrike Burk may publish in the future.
Co-authors
The 25 scholars most cited alongside Ulrike Burk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A reciprocal repression between ZEB1 and members of the miR‐200 family promotes EMT and invasion in cancer cells Hit paper breakdown → | 2008 | 1432 |
| 2 | The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs Hit paper breakdown → | 2009 | 1380 |
| 3 | 2011 | 300 | |
| 4 | 2015 | 188 | |
| 5 | 2007 | 124 | |
| 6 | 2008 | 78 | |
| 7 | 2011 | 49 | |
| 8 | 2019 | 34 | |
| 9 | 2015 | 22 | |
| 10 | 2022 | 18 | |
| 11 | 2019 | 11 | |
| 12 | 1995 | 6 | |
| 13 | 2020 | 3 | |
| 14 | 1995 | 1 |
About Ulrike Burk
Ulrike Burk is a scholar working on Molecular Biology, Oncology, Cancer Research, Surgery and Genetics, having authored 14 papers that have together received 3.6k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (5 papers), Cancer Cells and Metastasis (3 papers), Pancreatic function and diabetes (2 papers), Cancer-related molecular mechanisms research (2 papers), Advanced biosensing and bioanalysis techniques (1 paper), Signaling Pathways in Disease (1 paper), Metabolism, Diabetes, and Cancer (1 paper) and Kruppel-like factors research (1 paper). The work is most often cited by research in Cancer Research (1.9k citations), Oncology (1.4k citations), Molecular Biology (2.7k citations), Cell Biology (220 citations) and Immunology (196 citations). Ulrike Burk has collaborated with scholars based in Germany, United Kingdom and United States. Frequent co-authors include Thomas Brabletz, Ulrich F. Wellner, Jörg Schubert, Otto Schmalhofer, Simone Spaderna, Elizabeth Vincan, Simone Brabletz, Marc P. Stemmler, Julia Schüler and Tobias Keck. Their work appears in journals such as International Journal of Oncology, The EMBO Journal, Nature Cell Biology, BMC Systems Biology and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.